Stay updated on Carboplatin and Nivolumab in mTNBC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin and Nivolumab in mTNBC Clinical Trial page.

Latest updates to the Carboplatin and Nivolumab in mTNBC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision label v3.3.4 was added and v3.3.3 was removed, a minor metadata update that does not affect study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe Locations section now lists additional sites: Connecticut, Maine, Massachusetts, New Hampshire, Ohio, and Vermont. The HHS Vulnerability Disclosure notice was removed and the page revision updated to v3.3.3.SummaryDifference0.6%

- Check59 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2 in the metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedThe government funding-status notice was removed from the page. Core trial information such as the study details, locations, and eligibility criteria remains unchanged.SummaryDifference0.3%

- Check81 days agoChange DetectedMinor formatting adjustments and small textual updates observed; no substantive changes to study design, eligibility criteria, interventions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check110 days agoChange DetectedMajor updates to status and revision information, plus a new government-operating notice; earlier dates and version v3.1.0 were removed and newer dates with version v3.2.0 added.SummaryDifference2%

Stay in the know with updates to Carboplatin and Nivolumab in mTNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin and Nivolumab in mTNBC Clinical Trial page.